首页> 外文OA文献 >Clinical Value and Optimal Timing of Cranial Local Therapy among EGFR-Mutant Non-small-cell Lung Cancer with Brain Metastases in the Era of Osimertinib

【2h】

Clinical Value and Optimal Timing of Cranial Local Therapy among EGFR-Mutant Non-small-cell Lung Cancer with Brain Metastases in the Era of Osimertinib

机译：Egfr-突变体非小细胞肺癌中颅局局部治疗的临床价值与脑转移中脑转移中的临床价值及最佳时间

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
F. Yu; J. Ni; W. Yu; X. Fu; Z. Zhu;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Optimal Sequence of Local and EGFR-TKI Therapy for EGFR-Mutant Non-Small Cell Lung Cancer With Brain Metastases Stratified by Number of Brain Metastases [J] . Miyawaki Eriko, Kenmotsu Hirotsugu, Mori Keita, International Journal of Radiation Oncology, Biology, Physics . 2019,第3期

机译：局部和EGFR-TKI治疗的最佳序列与脑转移脑转移的脑转移中的EGFR-突变体非小细胞肺癌治疗
2. Complete Remission of Multiple Brain Metastases in a Patient with EGFR-Mutated Non-Small-Cell Lung Cancer Treated with First-Line Osimertinib without Radiotherapy [J] . Koken Ameku, Mariko Higa Case Reports in Oncological Medicine . 2020,第3期

机译：在没有放射治疗的无放射治疗的患者中完全缓解患有EGFR突变的非小细胞肺癌的患者
3. Optimal timing and clinical value of radiotherapy in advanced ALK -rearranged non-small cell lung cancer with or without baseline brain metastases: implications from pattern of failure analyses [J] . Jianjiao Ni, Guodong Li, Xi Yang, Radiation oncology . 2019,第1期

机译：晚期ALK重排非小细胞肺癌伴或不伴基线脑转移的放疗最佳时机和临床价值：失败分析模式的启示
4. CT image fusion in the optimization of replanning during the course of 3-dimensional conformal radiotherapy for non-small-cell lung cancer [C] . Xu XiMing, Deng JunJian, Guo HongTing, 2010 3rd International Conference on Biomedical Engineering and Informatics . 2010

机译：非小细胞肺癌3D立体适形放疗过程中CT图像融合对重新计划的优化
5. Use of Palliative Radiotherapy Among Metastatic Non-small-cell Lung Cancer (NSCLC) Patients in Puerto Rico [D] . ?Quinones Avila, Valerie 2020

机译：在波多黎各的转移性非小细胞肺癌（NSCLC）患者中使用姑息放射治疗
6. Complete Remission of Multiple Brain Metastases in a Patient with EGFR-Mutated Non-Small-Cell Lung Cancer Treated with First-Line Osimertinib without Radiotherapy [O] . Koken Ameku, Mariko Higa 2020

机译：一线奥西替尼治疗未经放射治疗的EGFR突变非小细胞肺癌患者的多发脑转移完全缓解
7. A phase II, multicenter, two cohort study of 160 mg osimertinib in EGFR T790M-positive non-small-cell lung cancer patients with brain metastases or leptomeningeal disease who progressed on prior EGFR TKI therapy [O] . S. Park, M.-H. Lee, M. Seong, 2020

机译：在EGFR T790M阳性非小细胞肺癌患者中，患有脑转移或先前EGFR TKI治疗的脑转移或脑病疾病中的160mg Osimertinib的二阶段，两组队列研究

Clinical Value and Optimal Timing of Cranial Local Therapy among EGFR-Mutant Non-small-cell Lung Cancer with Brain Metastases in the Era of Osimertinib

著录项

引文网络

相似文献

相关主题

期刊订阅